会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 71. 发明授权
    • Lymphotoxin DNA, lymphotoxin expression vector
    • 淋巴毒素DNA,淋巴毒素表达载体
    • US4988624A
    • 1991-01-29
    • US882109
    • 1986-07-03
    • Tetsu KakutaniKenji Yamashitayasuhiro IkenakaHajime KawaharadaKiyoshi Watanabe
    • Tetsu KakutaniKenji Yamashitayasuhiro IkenakaHajime KawaharadaKiyoshi Watanabe
    • C07K14/525C12N15/19C12N15/85
    • C07K14/525C12N15/85
    • A chromosomal DNA sequence which codes for human lymphotoxin, a lymphotoxin expression vector which contains a DNA sequence wherein a chromosomal DNA sequence coding for human lymphotoxin and promoter region which functions in animal cell are linked together, lymphotoxin resistant cell line, transformed animal cell culture which is formed by transforming cultured animal cell with a lymphotoxin expression vector which contains a chromosomal DNA sequence coding for human lymphotoxin and, a process for preparing human lymphotoxin, which comprises transforming cultured animal cell with a lymphotoxin expression vector which contains a chromosomal DNA sequence coding for human lymphotoxin, culturing the transformed cell culture to produce human lymphotoxin, and collecting the human lymphotoxin.According to the present invention, LT which is expected for application as the antitumor agent can be produced effectively in a large amount.
    • 编码人淋巴毒素的染色体DNA序列,含有DNA序列的淋巴毒素表达载体,其中编码人类淋巴毒素的染色体DNA序列和在动物细胞中起作用的启动子区连接在一起,淋巴毒素抗性细胞系,转化的动物细胞培养物 是通过用含有编码人淋巴毒素的染色体DNA序列的淋巴毒素表达载体转化培养的动物细胞,以及制备人淋巴毒素的方法形成的,其包括用含有染色体DNA序列编码的淋巴毒素表达载体转化培养的动物细胞, 人淋巴毒素,培养转化的细胞培养物以产生人淋巴毒素,并收集人淋巴毒素。 根据本发明,可以有效地大量生产预期用作抗肿瘤剂的LT。
    • 76. 发明授权
    • Process for preparing optically active glycerol derivatives
    • 光学活性甘油衍生物的制备方法
    • US4863859A
    • 1989-09-05
    • US822494
    • 1986-01-27
    • Shigeki HamaguchiTakehisa OhashiKiyoshi Watanabe
    • Shigeki HamaguchiTakehisa OhashiKiyoshi Watanabe
    • C12P11/00C12P41/00
    • C12P41/004C12P11/00
    • A process for preparing optically active glycerol derivatives by a biochemical resolution which comprises (i) subjecting an ester having the general formula [(R,S)-I]: ##STR1## wherein X is a halogen atom, R is an aliphatic hydrocarbon group of C.sub.1 to C.sub.8 and R' is an aromatic hydrocarbon group or an aliphatic hydrocarbon group of C.sub.1 to C.sub.2, to the action of enzymes derived from either microorganisms or animal organs, wherein said enzymes have a stereo selective esterase activity to asymmetrically hydrolyze the ester having the general formula [(R,S)-I] to give a mixture of an optically active alcohol having the general formula (II)*: ##STR2## wherein X and R' are as above and an optically active ester having the general formula (I)*: ##STR3## wherein X, R and R' are as above, and (ii) obtaining the optically active alcohol having the general formula (II)* and the optically active ester having the general formula (I)* by separating operations.In accordance with the present invention, there can be provided a process for preparing optically active glycerol derivatives, wherein the optically active ester having the general formula (I)* and the optically active alcohol having the general formula (II)* can be easily obtained.
    • 一种通过生化分解制备光学活性甘油衍生物的方法,其包括(i)使具有通式[(R,S)-I]的酯:其中X为 卤素原子,R是C1至C8的脂族烃基,R'是C1至C2的芳族烃基或脂族烃基,来自微生物或动物器官的酶的作用,其中所述酶具有立体声 选择性酯酶活性以不对称地水解具有通式[(R,S)-I]的酯,得到具有通式(II)的光学活性醇的混合物:其中X和R (I)*:其中X,R和R'如上所述,和(ii)获得具有通式(I)的光学活性酯,其具有通式(I) II)*和具有通式(I)*的光学活性酯通过分离操作。 根据本发明,可以提供一种制备光学活性甘油衍生物的方法,其中可以容易地获得具有通式(I)*的光学活性酯和具有通式(II)*的光学活性醇 。